We are thrilled to announce that Healthcare Pharmaceuticals Limited (HPL) has been awarded the prestigious European Union Good Manufacturing Practice (EU GMP) certificate for Oncology. This certification, valid for three years, marks a significant milestone in our journey towards global excellence in pharmaceutical manufacturing.

Achieving EU GMP certification was no easy feat. The path was filled with challenges and moments of uncertainty, but through resilience, unwavering dedication, and collective effort, we have reached this remarkable success. This recognition underscores our steadfast commitment to maintaining the highest standards of quality, safety, and compliance on an international scale.

This monumental achievement is the realization of the vision and aspiration of our esteemed Deputy Managing Director & CEO, Mr. Md Halimuzzaman. His steadfast support, perseverance, and belief in the HPL team have been instrumental in turning this dream into reality after a long and determined journey.

At HPL, we remain dedicated to innovation and excellence in healthcare, ensuring that our oncology products meet the stringent requirements of global markets. This EU GMP certification is not just an accolade—it is a testament to our promise of delivering world-class pharmaceuticals that improve lives.